Related Experiment Video
Updated: Feb 9, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
PPARgamma-mediated ALDH1A3 suppression exerts anti-proliferative effects in lung cancer by inducing lipid
Tuyen N M Hua1,2, Jun Namkung1, Ai N H Phan1,2
1a Department of Biochemistry, Wonju College of Medicine , Yonsei University , Wonju , South Korea.
Context:
The metabolic function of peroxisome proliferator-activated receptor gamma (PPARγ) in lung cancer remains unclear.
Objectives:
To determine the relationship of PPARγ on ALDH1A3-induced lipid peroxidation to inhibit lung cancer cell growth.
Materials And Methods:
In silico analysis using microarray dataset was performed to screen the positive correlation between PPARγ and all ALDH isoforms. NUBIscan software and ChIP assay were used to identify the binding sites (BSs) of PPARγ on ALDH1A3 promoter. The expression of ALDH1A3 under thiazolidinedione (TZD) treatment was evaluated by QPCR and Western Blot in HBEC and H1993 cell lines. Upon treatment of TZD, colony formation assay was used to check cell growth inhibition and 4-hydroxy-2-nonenal (4HNE) production as lipid peroxidation marker was determined by Western Blot in PPARγ positive cell H1993 and PPARγ negative cell H1299.
Results:
Compared to other ALDH isoforms, ALDH1A3 showed the highest positive correlation to PPARγ expression. ALDH1A3 upregulated PPARγ expression while PPARγ activation suppressed ALDH1A3. Among 2 potential screened PPARγ response elements, BS 1 and 2 in the promoter of ALDH1A3 gene, PPARγ bound directly to BS2. Ligand activation of PPARγ suppressed mRNA and protein expression of ALDH1A3. Growth inhibition was observed in H1993 (PPARγ positive cell) treated with PPARγ activator and ALDH inhibitor compared to H1299 (PPARγ negative cell). PPARγ activation increased 4HNE which is known to be suppressed by ALDH1A3.
Conclusions:
ALDH1A3 suppression could be one of PPARγ tumor suppressive function. This study provides a better understanding of the role of PPARγ in lung cancer.
Insights
Peroxisome proliferator-activated receptor gamma (PPARγ) activation suppresses aldehyde dehydrogenase 1A3 (ALDH1A3) expression, inhibiting lung cancer cell growth and increasing lipid peroxidation. This suggests PPARγ has a tumor-suppressive role in lung cancer.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- The role of peroxisome proliferator-activated receptor gamma (PPARγ) in lung cancer metabolism is not well understood.
- Investigating PPARγ's function is crucial for developing new lung cancer therapies.
Purpose of the Study:
- To elucidate the relationship between PPARγ and aldehyde dehydrogenase 1A3 (ALDH1A3) in lung cancer.
- To determine how PPARγ influences ALDH1A3-induced lipid peroxidation and lung cancer cell proliferation.
Main Methods:
- In silico analysis of microarray data to identify correlations between PPARγ and ALDH isoforms.
- ChIP assay and NUBIscan software to pinpoint PPARγ binding sites on the ALDH1A3 promoter.
- Quantitative PCR, Western Blot, and colony formation assays to assess gene expression, protein levels, cell growth, and lipid peroxidation (4-hydroxy-2-nonenal).
Main Results:
- ALDH1A3 demonstrated the strongest positive correlation with PPARγ expression among all ALDH isoforms.
- PPARγ directly bound to a specific site (BS2) on the ALDH1A3 promoter, suppressing its mRNA and protein expression.
- PPARγ activation inhibited lung cancer cell growth and increased lipid peroxidation marker 4-hydroxy-2-nonenal (4HNE) in PPARγ-positive cells.
Conclusions:
- Aldehyde dehydrogenase 1A3 (ALDH1A3) suppression is a potential mechanism for the tumor-suppressive function of PPARγ in lung cancer.
- This research enhances the understanding of PPARγ's multifaceted role in lung cancer progression and provides a basis for targeted therapeutic strategies.
More Related Videos
07:43Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients
Published on: September 25, 2018
05:21Author Spotlight: Optimizing Antibody-Based Cancer Treatments via Antibody-Dependent, Cell-Mediated Cytotoxicity Assay
Published on: September 13, 2024
Related Concept Videos
Proliferative Phase
Notably, the stratum basale, the basal layer of the endometrium, including the basal parts of the uterine glands, remains unaffected by menstruation. Stem cells in this layer undergo mitosis, regenerating the stratum functionalis and thickening the...
Receptor-mediated Endocytosis
What are Lipids?
Lipid Digestion
Mechanisms of Retrovirus-induced Cancers
Structure of Lipids